Eversource Takes Regulators Reset: ROE Drag Deepens
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
Learn when to rebalance dividend ETFs in retirement with simple, actionable guidance. This concise intro explains timing cues and practical steps for steady retirement income.
12,627 articlesFederal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
A major energy partnership could reshape Chevron's cash flow and the stock's appeal before 2027. This guide breaks do...
Oil markets are in flux, and Occidental faces a pivotal year. This guide breaks down what to expect from occidental (...
As inflation sticks and volatility rises, investors are eyeing defensive income. This story flags five high-yield div...
This in-depth analysis breaks down Celanese’s 2025 earnings trajectory, highlighting drivers, margins, and cash flow....
Investors chasing income are eyeing three high-yield dividend stocks flashing warning signs as coverage tightens and ...
Two Dividend Kings anchor Berkshire Hathaway's core holdings as Greg Abel takes the helm. Analysts say Coca-Cola and ...
Colgate-Palmolive posted stronger-than-expected Q1 2026 results, setting the stage for upside despite tariff headwind...
Investors are shifting away from speculative hydrogen plays toward a blue-chip, high-yield industrial stock. Here’s w...
A wave of positive economic data has the Fed blinking toward rate cuts, yet stock investors fret about what comes nex...
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
Choosing between a standard financial sector ETF and a leveraged option is more than a price tag. This guide breaks d...